Search Results

You are looking at 91 - 100 of 817 items for :

  • "risk factor" x
  • Refine by Access: All x
Clear All
Full access

Sofia D. Merajver and Kara Milliron

National Cancer Data Base, 2000 . CA Cancer J Clin 2000 ; 50 : 171 – 183 . 3 Dupont WD Page DL . Risk factors for breast cancer in women with proliferative breast disease . N Engl J Med 1985 ; 312 : 146 – 151 . 4 Slattery ML

Full access

Tobin Strom, Javier F. Torres-Roca, Akash Parekh, Arash O. Naghavi, Jimmy J. Caudell, Daniel E. Oliver, Jane L. Messina, Nikhil I. Khushalani, Jonathan S. Zager, Amod Sarnaik, James J. Mulé, Andy M. Trotti, Steven A. Eschrich, Vernon K. Sondak, and Louis B. Harrison

Background Node-positive cutaneous melanoma is heterogeneous, with 5-year survival rates ranging from 40% to 79%. 1 Many risk factors have been shown to be generally associated with regional recurrence following lymphadenectomy, including

Full access

Yi-Nong Chen, Ching-Wen Chiang, Yu-Hsiang Tsai, Wan-Ming Chen, Mingchih Chen, Ben-Chang Shia, Chun-Chi Huang, and Szu-Yuan Wu

of postoperative pneumonia (POP), which is high in patients with OCSCC who receive curative surgery, contributed to the high mortality and morbidity of these patients. 12 – 14 Consequently, identifying a modifiable risk factor for POP is crucial for

Full access

Krisda H. Chaiyachati, Diana Krause, Jessica Sugalski, Evan M. Graboyes, and Lawrence N. Shulman

infrastructure that is not suitable for patients with cancer; and inability to access ride services. 1 , 2 Transportation insecurity is a social risk factor 3 —adverse social conditions associated with poor health—that frequently co-occurs with other social risk

Full access

Julie R. Gralow, J. Sybil Biermann, Azeez Farooki, Monica N. Fornier, Robert F. Gagel, Rashmi Kumar, Georgia Litsas, Rana McKay, Donald A. Podoloff, Sandy Srinivas, and Catherine H. Van Poznak

effects on bone metabolism. The hormone deprivation state resulting from certain cancer therapies enhances osteoclastic bone resorption, promoting bone loss. Osteoporosis risk factors unique to patients with cancer include chemotherapy-induced menopause

Full access

Jeffrey Crawford, David C. Dale, Nicole M. Kuderer, Eva Culakova, Marek S. Poniewierski, Debra Wolff, and Gary H. Lyman

2005 ; 23 : 569 – 575 . 16. Lyman GH Lyman CH Agboola O . Risk models for predicting chemotherapy-induced neutropenia . Oncologist 2005 ; 10 : 427 – 437 . 17. Gomez H Hidalgo M Casanova L . Risk factors for treatment

Full access

John Charlson, Elizabeth C. Smith, Alicia J. Smallwood, Purushottam W. Laud, and Joan M. Neuner

along with other risk factors for fracture. 3 , 5 – 8 Although a few studies early in the use of AIs suggested that adherence to these guidelines was suboptimal, 9 – 13 there are few recent data. As consensus about the importance of AIs in HT regimens

Full access

Pilar de la Morena Barrio, María Ángeles Vicente Conesa, Enrique González-Billalabeitia, Edgar Urrego, Elisa García-Garre, Elena García-Martínez, Marta Zafra Poves, Vicente Vicente, and Francisco Ayala de la Peña

have DM. 14 , 15 Because DM is itself a cause of peripheral neuropathy, PIPN might be more prevalent and severe in patients with breast cancer and DM. However, the available evidence is limited for considering DM a risk factor for PIPN. Several case

Full access

Mathias Kvist Mejdahl, Birgitte Goldschmidt Mertz, Pernille Envold Bidstrup, and Kenneth Geving Andersen

Identify psychological risk factors for PPBCT that may be targeted in preventive interventions Background Persistent pain after breast cancer treatment (PPBCT) affects 25% to 60% of patients treated for breast cancer, 1 may persist for

Full access

Monira Alwhaibi, Usha Sambamoorthi, Suresh Madhavan, Thomas Bias, Kimberly Kelly, and James Walkup

). These dimensions are an individual's physical make-up, social support, access to care, health behaviors, psychological factors, biological risk factors, treatment factors, community resources, and geographic region. Methods Data Source SEER